In the Democratic Republic of Congo, where an Ebola outbreak has claimed more than 3,000 lives since May 2026, children under five are dying at rates exceeding 60 percent — not always because the virus is more ferocious in small bodies, but because the medicines and trials designed to fight it were not designed with them in mind. The exclusion of children from clinical research is not a new failure; it is a recurring one, repeated across mpox, HIV, tuberculosis, and COVID-19, rooted in the quiet logic that studying adults first is faster and cheaper. What the DRC outbreak makes visible, once a
Ebola's Hidden Crisis: Why Children Are Excluded From Life-Saving Treatments
Over 3,000 deaths since May 2026 in DRC Ebola outbreak; children under 5 face mortality rates exceeding 60% due to treatment gaps.